Envestnet Portfolio Solutions’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,421
Closed -$286K 1552
2025
Q2
$286K Sell
12,421
-3,881
-24% -$89.9K ﹤0.01% 1358
2025
Q1
$366K Sell
16,302
-4,374
-21% -$102K ﹤0.01% 1188
2024
Q4
$404K Sell
20,676
-697
-3% -$13.8K ﹤0.01% 1340
2024
Q3
$389K Sell
21,373
-693
-3% -$13.2K ﹤0.01% 1321
2024
Q2
$384K Sell
22,066
-3,312
-13% -$58.7K ﹤0.01% 1248
2024
Q1
$497K Buy
25,378
+3,487
+16% +$73.7K ﹤0.01% 1125
2023
Q4
$504K Buy
21,891
+4,435
+25% +$99.3K ﹤0.01% 1047
2023
Q3
$401K Buy
+17,456
New +$444K ﹤0.01% 1079

Other funds holding PRVA

Envestnet Portfolio Solutions's PRVA Position: Q3 2025 in Review

Envestnet Portfolio Solutions sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 12,421 shares — an estimated $286K sold.

Envestnet Portfolio Solutions first reported a position in PRVA in Q3 2023 and held it in 8 quarters. The position peaked at $504K in Q4 2023. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Envestnet Portfolio Solutions reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 12,421 Privia Health shares in Q3 2025, an estimated $286K.
  • Envestnet Portfolio Solutions first reported a position in Privia Health in Q3 2023 and held it in 8 quarters.
  • Envestnet Portfolio Solutions's Privia Health position peaked at $504K in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Envestnet Portfolio Solutions's 13F filing for Q3 2025, filed 30 Oct 2025.